On the Media (WNYC/NPR)
Money Talks
Pharmaceutical companies spend millions on marketing. Some of those dollars end up in the hands of doctors, researchers and in one case, a public radio host from "The Infinite Mind." An article in Slate back in May led to an investigation by Sen. Charles Grassley, whose findings ended up in a New York Times piece last week. We spoke with NPR's David Folkenflik and Sen. Grassley about the controversy.
Gateway Drugs
A journalist’s non-disclosure of millions in pharmaceutical company payments is an obvious conflict of interest. But Gary Schwitzer, director of the University of Minnesota’s Health Journalism Program, explains that what’s ailing news consumers is all the other subtle, insidious ways that Big Pharma’s influence turns up in the news we use.
No comments:
Post a Comment